Hypercholesterolemia as a risk factor for depressive disorder?

Area of Science:

• Neuroscience
• Biochemistry
• Genetics

Background:

• Epidemiological studies link elevated plasma cholesterol to depression.
• Hypercholesterolemia is increasingly associated with cognitive and brain function impairments.
• Low-density lipoprotein receptor knockout (LDLr(-/-)) mice, a model for familial hypercholesterolemia, exhibit memory deficits and mitochondrial dysfunction.

Purpose of the Study:

• To investigate the impact of hypercholesterolemia on depressive-like behaviors in LDLr(-/-) mice.
• To explore the underlying neurobiological mechanisms, including monoamine oxidase activity, hemeoxygenase-1 levels, and blood-brain barrier permeability.

Main Methods:

• Adult wild-type and LDLr(-/-) mice were assessed using the splash test and forced swimming test.
• Monoamine oxidase activity and hemeoxygenase-1 mRNA levels were measured in the hippocampus and cerebral cortex.
• Blood-brain barrier permeability was evaluated via AQP-4 immunofluorescence staining.

Main Results:

• LDLr(-/-) mice displayed reduced grooming and increased immobility, indicative of depressive-like behavior.
• Fluoxetine treatment reversed these behavioral changes.
• Hypercholesterolemia was associated with increased monoamine oxidase A activity, decreased hemeoxygenase-1 mRNA, and elevated blood-brain barrier permeability in the hippocampus.

Conclusions:

• Hypercholesterolemia can induce brain alterations that contribute to depressive disorders.
• These findings highlight a potential biological link between high cholesterol levels and the pathophysiology of depression.
• Targeting cholesterol metabolism may offer novel therapeutic strategies for depression.